Assessment of risk factors in patients treated for multivessel disease A multivariate analysis of major cardiac and cerebrovascular events in the ARTS study

Patrick W. Serruys; Vasil'eva Lk; Florian T. Unger; Gerhard Schuler; F. W. Mohr; G. Heyer; C Macaya; José L. Castanon; Marie-Angèle Morel; Wietze Lindeboom

Back

Assessment of risk factors in patients treated for multivessel disease A multivariate analysis of major cardiac and cerebrovascular events in the ARTS study

Article 2000 English

Related publications

Article2003

Fluvastatin prevents cardiac events following successful percutaneous coronary intervention in patients with multivessel disease: The lescolfi intervention prevention study

Pedro A. Lemos, G. Boxho, Dick Goedhart, Brian J. O’Neil, J. P. Broustet, Gunnar H. Berghoefer, C. Alonso, A. Boehmer, Pim de Feyter, Patrick W. Serruys

Journal of the American College of Cardiology

Article2010

MULTIVESSEL CORONARY REVASCULARIZATION IN PATIENTS WITH AND WITHOUT DIABETES MELLITUS 5-YEAR FOLLOW-UP OF THE ARTS-II TRIAL (ARTERIAL REVASCULARIZATION THERAPIES STUDY-PART II)

Yoshinobu Onuma, Joanna J. Wykrzykowska, Pascal Vranckx, Patrick W. Serruys, the ARTS-II Investigators

Journal of the American College of Cardiology

Article1990

Probability and prognostic factors of the first encephalopathy episode in advanced liver cirrhosis: A multivariate analysis

A. Abad-L, F. Glez-Huix, Eduard Cabré, C. Gomes-Vieira, Josep M. Llovet, María Esteve, F. Fdez-Bañares, P Humbert, M.A. Gassull

Journal of Hepatology

Article1985

Single vessel dilatation in patients with unstable angina and multivessel disease

Alfred Arnold, Marcel van den Brand, Patrick W. Serruys, William Wijns, Renè Geuskens

Chapter in a book1994

Quantitative coronary angiography in the assessment of risk factors for luminal renarrowing

Walter Hermans, Benno J. Rensing, Patrick W. Serruys

Assessment of risk factors in patients treated for multivessel disease A multivariate analysis of major cardiac and cerebrovascular events in the ARTS study

Abstract

Discussion(0)

Related publications

Fluvastatin prevents cardiac events following successful percutaneous coronary intervention in patients with multivessel disease: The lescolfi intervention prevention study

MULTIVESSEL CORONARY REVASCULARIZATION IN PATIENTS WITH AND WITHOUT DIABETES MELLITUS 5-YEAR FOLLOW-UP OF THE ARTS-II TRIAL (ARTERIAL REVASCULARIZATION THERAPIES STUDY-PART II)

Probability and prognostic factors of the first encephalopathy episode in advanced liver cirrhosis: A multivariate analysis

Single vessel dilatation in patients with unstable angina and multivessel disease

Quantitative coronary angiography in the assessment of risk factors for luminal renarrowing